These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 23083418)

  • 1. BK virus viremia in a well-HLA-matched kidney transplant population mainly on low-dose cyclosporine-based immunosuppression.
    Helanterä I; Salmela K; Kyllönen L; Räisänen-Sokolowski A; Auvinen E; Mannonen L; Koskinen P; Lautenschlager I
    Clin Transplant; 2012; 26(6):E596-601. PubMed ID: 23083418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
    Puliyanda DP; Amet N; Dhawan A; Hilo L; Radha RK; Bunnapradist S; Czer L; Martin P; Jordan S; Toyoda M
    Clin Transplant; 2006; 20(3):289-94. PubMed ID: 16824143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.
    Gabardi S; Townsend K; Martin ST; Chandraker A
    Transpl Infect Dis; 2013 Aug; 15(4):361-8. PubMed ID: 23647907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective monitoring of BK virus replication in renal transplant recipients.
    Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
    Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy.
    Schaub S; Hirsch HH; Dickenmann M; Steiger J; Mihatsch MJ; Hopfer H; Mayr M
    Am J Transplant; 2010 Dec; 10(12):2615-23. PubMed ID: 21114642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection.
    Jha A; Ahmed W; Pakkyara A; Shaheen F; Al Salmi I
    Saudi J Kidney Dis Transpl; 2018; 29(5):1073-1081. PubMed ID: 30381503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BK virus nephropathy in renal transplant recipients in Kuwait: a preliminary report.
    Nampoory MR; Johny KV; Pacsa A; Nair PM; Said T; Halim MA; Francis I; Samhan M; Mousawi M; Dalawi A; Szucs G; Al-Nakib W
    Transplant Proc; 2005 Sep; 37(7):3048-50. PubMed ID: 16213300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
    Westphal SG; Lyden ER; Langewisch ED; Miles CD
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population.
    Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z
    Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
    Broeders EN; Hamade A; El Mountahi F; Racapé J; Hougardy JM; Le Moine A; Vereerstraeten P
    Transpl Infect Dis; 2016 Dec; 18(6):872-880. PubMed ID: 27615506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
    Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
    Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients.
    Rampersad C; Wiebe C; Balshaw R; Bullard J; Gibson IW; Trachtenberg A; Shaw J; Villalobos APC; Karpinski M; Goldberg A; Birk P; Pinsk M; Rush DN; Nickerson PW; Ho J
    Clin Transplant; 2024 May; 38(5):e15329. PubMed ID: 38722085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A kidney transplant recipient with renal medullary viral cytopathic changes.
    Ramanan P; Timmerman EA; Fidler ME; Amer H; Pritt BS; Schwab DA; Batterman HJ; Binnicker MJ
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27925350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy.
    Radtke J; Dietze N; Fischer L; Achilles EG; Li J; Scheidat S; Thaiss F; Nashan B; Koch M
    Transpl Infect Dis; 2016 Dec; 18(6):850-855. PubMed ID: 27639176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
    Hässig A; Roos M; Etter A; Bossart W; Müller N; Schiesser M; Wüthrich RP; Fehr T
    Transpl Infect Dis; 2014 Feb; 16(1):44-54. PubMed ID: 24134704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
    Ji J; Feng S; Jiang Y; Wang W; Zhang X
    Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of BK viral infection after alemtuzumab induction for renal transplant.
    Cannon RM; Brock G; Marvin MR; Eng M; Buell JF
    Transpl Infect Dis; 2012 Aug; 14(4):374-9. PubMed ID: 22136487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.